ALVAC-CEA B7.1 vaccine
Term · Oncology and biomedicine · MLC-T-ONC-010005
A cancer vaccine that uses a viral vector system derived from the canarypox virus engineered to target the carcinoembryonic antigen (CEA). It causes infected cells to temporarily display CEA and activates the immune system to attack the tumor cells.
| Identifier | MLC-T-ONC-010005 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010005",
"term": "ALVAC-CEA B7.1 vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine that uses a viral vector system derived from the canarypox virus engineered to target the carcinoembryonic antigen (CEA). It causes infected cells to temporarily display CEA and activates the immune system to attack the tumor cells.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/alvac-cea-b7-1-vaccine/"
}
Record 920 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.